La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Neuroprotective Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroprotection < Neuroprotective Agents < Neuropsychological Tests  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 52.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000242 (2015) S. Abdelsayed ; N T Ha Duong ; C. Bureau ; P P Michel ; E C Hirsch ; J M El Hage Chahine ; N. SerradjiPiperazine derivatives as iron chelators: a potential application in neurobiology.
000276 (2015) Hocine Rekaik ; François-Xavier Blaudin De Thé ; Julia Fuchs ; Olivia Massiani-Beaudoin ; Alain Prochiantz ; Rajiv L. JoshiEngrailed Homeoprotein Protects Mesencephalic Dopaminergic Neurons from Oxidative Stress.
000311 (2015) Cristiane Latge ; Katia M S. Cabral ; Guilherme A P. De Oliveira ; Diana P. Raymundo ; Julia A. Freitas ; Laizes Johanson ; Luciana F. Romão ; Fernando L. Palhano ; Torsten Herrmann ; Marcius S. Almeida ; Debora FoguelThe Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers.
000412 (2015) Gael Le Douaron ; Fanny Schmidt ; Majid Amar ; Hanane Kadar ; Lucila Debortoli ; Alexandra Latini ; Blandine Séon-Méniel ; Laurent Ferrié ; Patrick Pierre Michel ; David Touboul ; Alain Brunelle ; Rita Raisman-Vozari ; Bruno FigadèreNeuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
000442 (2015) Mariza Bortolanza ; Roberta Cavalcanti-Kiwiatkoski ; Fernando E. Padovan-Neto ; Célia Aparecida Da-Silva ; Miso Mitkovski ; Rita Raisman-Vozari ; Elaine Del-BelGlial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
000518 (2014) Franziska Richter ; Fuying Gao ; Vera Medvedeva ; Patrick Lee ; Nicholas Bove ; Sheila M. Fleming ; Magali Michaud ; Vincent Lemesre ; Stefano Patassini ; Krystal De La Rosa ; Caitlin K. Mulligan ; Pedrom C. Sioshansi ; Chunni Zhu ; Giovanni Coppola ; Thierry Bordet ; Rebecca M. Pruss ; Marie-Françoise ChesseletChronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
000523 (2014) Anthony H V. Schapira ; C Warren Olanow ; J Timothy Greenamyre ; Erwan BezardSlowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
000549 (2014) David Devos ; Caroline Moreau ; David Maltête ; Romain Lefaucheur ; Alexandre Kreisler ; Alexandre Eusebio ; Gilles Defer ; Thavarak Ouk ; Jean-Philippe Azulay ; Pierre Krystkowiak ; Tatiana Witjas ; Marie Delliaux ; Alain Destée ; Alain Duhamel ; Régis Bordet ; Luc Defebvre ; Kathy DujardinRivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
000559 (2014) César L. Ávila ; Clarisa M. Torres-Bugeau ; Leandro R S. Barbosa ; Elisa Morandé Sales ; Mohand O. Ouidja ; Sergio B. Socías ; M Soledad Celej ; Rita Raisman-Vozari ; Dulce Papy-Garcia ; Rosangela Itri ; Rosana N. ChehínStructural characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase protofibrils preventing α-synuclein oligomeric species toxicity.
000576 (2014) V. Procaccio ; C. Bris ; J M Chao De La Barca ; F. Oca ; A. Chevrollier ; P. Amati-Bonneau ; D. Bonneau ; P. ReynierPerspectives of drug-based neuroprotection targeting mitochondria.
000589 (2014) P. Cesaro ; L. Defebvre[Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
000632 (????) Murat Emre ; Werner Poewe ; Peter Paul De Deyn ; Paolo Barone ; Jaime Kulisevsky ; Emmanuelle Pourcher ; Teus Van Laar ; Alexander Storch ; Federico Micheli ; David Burn ; Frank Durif ; Rajesh Pahwa ; Francesca Callegari ; Nadia Tenenbaum ; Christine StrohmaierLong-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.
000700 (2013) Fanny Duval ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
000744 (2013) Daniel Alvarez-Fischer ; Carmen Noelker ; Franca Vulinovi ; Anne Grünewald ; Caroline Chevarin ; Christine Klein ; Wolfgang H. Oertel ; Etienne C. Hirsch ; Patrick P. Michel ; Andreas HartmannBee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model.
000764 (2013) M. Amalric ; S. Lopez ; C. Goudet ; G. Fisone ; G. Battaglia ; F. Nicoletti ; J-P Pin ; F C AcherGroup III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.
000798 (2013) Erwan Bezard ; Zhenyu Yue ; Deniz Kirik ; Maria Grazia SpillantiniAnimal models of Parkinson's disease: limits and relevance to neuroprotection studies.
000837 (2012) Mickael Decressac ; Stéphanie Pain ; Pierre-Yves Chabeauti ; Laura Frangeul ; Nathalie Thiriet ; Herbert Herzog ; Jackie Vergote ; Sylvie Chalon ; Mohamed Jaber ; Afsaneh GaillardNeuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
000861 (2012) Antoine Fouillet ; Clemence Levet ; Angelique Virgone ; Marion Robin ; Pierre Dourlen ; Jennifer Rieusset ; Elise Belaidi ; Michel Ovize ; Monique Touret ; Serge Nataf ; Bertrand MollereauER stress inhibits neuronal death by promoting autophagy.
000954 (2011) Damien Toulorge ; Serge Guerreiro ; Audrey Hild ; Uwe Maskos ; Etienne C. Hirsch ; Patrick P. MichelNeuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+.
000B15 (2010) D. Devos ; R. Bordet ; L. Defebvre[Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
000C02 (2009) Etienne C. Hirsch ; Stéphane HunotNeuroinflammation in Parkinson's disease: a target for neuroprotection?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Neuroprotective Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Neuroprotective Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Neuroprotective Agents
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024